Zobrazeno 1 - 10
of 338
pro vyhledávání: '"Nelson B. Watts"'
Autor:
Chih-Hsing Wu, Wei-Chieh Hung, Ing-Lin Chang, Tsung-Ting Tsai, Yin-Fan Chang, Eugene V. McCloskey, Nelson B. Watts, Michael R. McClung, Chun-Feng Huang, Chung-Hwan Chen, Kun-Ling Wu, Keh-Sung Tsai, Ding-Cheng Chan, Jung-Fu Chen, Shih-Te Tu, Jawl-Shan Hwang, Weibo Xia, Toshio Matsumoto, Yoon-Sok Chung, Cyrus Cooper, John A. Kanis, Rong-Sen Yang, Wing P. Chan
Publikováno v:
Bone Reports, Vol 13, Iss , Pp 100729- (2020)
Objectives: Emerging evidence has indicated a role for pharmacologic agents in the primary prevention of osteoporotic fracture, but have not yet been systematically reviewed for meta-analysis. We conducted a meta-analysis to evaluate the efficacy of
Externí odkaz:
https://doaj.org/article/81a5d8098a084b9db4e9456be94af766
Autor:
Maria I. Danila, Ryan C. Outman, Elizabeth J. Rahn, Amy S. Mudano, Tammi F. Thomas, David T. Redden, Jeroan J. Allison, Fred A. Anderson, Julia P. Anderson, Peter M. Cram, Jeffrey R. Curtis, Liana Fraenkel, Susan L. Greenspan, Andrea Z. LaCroix, Sumit R. Majumdar, Michael J. Miller, Jeri W. Nieves, Monika M. Safford, Stuart L. Silverman, Ethel S. Siris, Daniel H. Solomon, Amy H. Warriner, Nelson B. Watts, Robert A. Yood, Kenneth G. Saag
Publikováno v:
Contemporary Clinical Trials Communications, Vol 4, Iss C, Pp 14-24 (2016)
Objective: To develop an innovative and effective educational intervention to inform patients about the need for osteoporosis treatment and to determine factors associated with its online uptake. Methods: Postmenopausal women with a prior fracture an
Externí odkaz:
https://doaj.org/article/b1b7fd3dfd104927af9608ad0e1a4158
Publikováno v:
Sensors, Vol 9, Iss 10, Pp 7957-7969 (2009)
This paper describes the development of a biosensor based on label-free immunosensing for the detection of the C-terminal telopeptide bone turnover marker from type-1 collagen. A self-assembled monolayer (SAM) of dithiodipropionic acid was deposited
Externí odkaz:
https://doaj.org/article/7be24ca293c2431ebebd1aacb4d9fd42
Autor:
Carolyn J. Crandall, Joseph C. Larson, John T. Schousboe, JoAnn E. Manson, Nelson B. Watts, John A. Robbins, Peter Schnatz, Rami Nassir, Aladdin H. Shadyab, Karen C. Johnson, Jane A. Cauley, Kristine E. Ensrud
Publikováno v:
JAMA Internal Medicine.
ImportanceThe best approach to identify younger postmenopausal women for osteoporosis screening is uncertain. The Fracture Risk Assessment Tool (FRAX), which includes self-identified racial and ethnic information, and the Osteoporosis Self-assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::eeef010ceec244bb0b29064c3e9eae1f
https://doi.org/10.1001/jamainternmed.2023.1253
https://doi.org/10.1001/jamainternmed.2023.1253
Autor:
Nelson B Watts, John P Bilezikian, Henry G Bone, Bart L Clarke, Douglas Denham, Michael A Levine, Michael Mannstadt, Munro Peacock, Jeffrey G Rothman, Tamara J Vokes, Mark L Warren, Shaoming Yin, Nicole Sherry, Dolores M Shoback
Publikováno v:
Journal of the Endocrine Society. 7
Context Chronic hypoparathyroidism is conventionally treated with oral calcium and active vitamin D to reach and maintain targeted serum calcium and phosphorus levels, but some patients remain inadequately controlled. Objective To assess long-term sa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e344cc593eb73b1899f4f9a228ac472
https://doi.org/10.1210/jendso/bvad043
https://doi.org/10.1210/jendso/bvad043
Autor:
Ayman Al-Hendy, Neil Binkley, Nelson B. Watts, Elizabeth E. Puscheck, James A. Simon, William D. Schlaff, Mohamad Shebley, Charlotte D. Owens
Publikováno v:
Journal of Women's Health. 30:1416-1430
Bone mineral density (BMD) changes during the life span, increasing rapidly during adolescence, plateauing in the third decade of life, and subsequently entering a phase of age-related decline. In women, menopause leads to accelerated bone loss and a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0ade8e5deb240b55b17f90f9d7db0f17
https://doi.org/10.1089/jwh.2020.8989
https://doi.org/10.1089/jwh.2020.8989
Autor:
Diddier Prada, Carolyn J. Crandall, Yike Shen, Allison Kupsco, Duanping Liao, James D. Stewart, Jeff D. Yanosky, Jean Wactawski-Wende, Nicole C. Wright, Nelson B. Watts, Longjian Liu, Aladdin H. Shadyab, Andrea Baccarelli, Eric Whitsel
Publikováno v:
ISEE Conference Abstracts. 2022
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2385c5263eee173d102c8885ee764836
https://doi.org/10.1289/isee.2022.p-0181
https://doi.org/10.1289/isee.2022.p-0181
Autor:
Dima L. Diab, Nelson B. Watts
Publikováno v:
Endocrinology and Metabolism Clinics of North America. 50:239-249
Osteoporosis is less common in men than women; however, the mortality rate associated with major fragility fractures is higher in men. The diagnosis of osteoporosis is established by measurement of bone mineral density or by the presence of a fragili
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e4d7a77362add8233a817e3ab08e5ca
https://doi.org/10.1016/j.ecl.2021.03.001
https://doi.org/10.1016/j.ecl.2021.03.001
Autor:
Yamei Wang, Sanford Baim, Nelson B. Watts, Robin K. Dore, Tamara D. Rozental, Gary Hattersley, Meryl S. LeBoff, Bruce H. Mitlak
Publikováno v:
Osteoporosis International
Summary Abaloparatide increased ultradistal radius bone mineral density (BMD) in the Abaloparatide Comparator Trial in Vertebral Endpoints (ACTIVE) trial. Over the subsequent 24 months in ACTIVExtend, ultradistal radius BMD gains were maintained with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0e8c00a526c2c8e5a2f908e56bfae19
https://doi.org/10.1007/s00198-020-05555-1
https://doi.org/10.1007/s00198-020-05555-1
Elagolix Treatment for Up to 12 Months in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas
Autor:
Jin Hee Kim, Ozgul Muneyyirci-Delale, Alice Wang, Ayman Al-Hendy, Kurt T. Barnhart, Nelson B. Watts, Eve C. Feinberg, Linda D. Bradley, James A. Simon, Sandra Hurtado, Bruce R. Carr, Ran Liu, William D. Schlaff, Veronica Gillispie, Thomas Dayspring, Charlotte D. Owens, David F. Archer
Publikováno v:
Obstetrics and Gynecology
Up to 12 months of elagolix with add-back therapy provided sustained reduction in menstrual blood loss with an acceptable safety profile in women with uterine leiomyomas.
OBJECTIVE: To investigate the safety and efficacy of elagolix, an oral gon
OBJECTIVE: To investigate the safety and efficacy of elagolix, an oral gon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::398f96820140237f230597448bc8c879
https://doi.org/10.1097/aog.0000000000003869
https://doi.org/10.1097/aog.0000000000003869